195 related articles for article (PubMed ID: 30908997)
41. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
Bhatt HG; Patel PK
Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
[TBL] [Abstract][Full Text] [Related]
42. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
Duan X; Zhang X; Xu B; Wang F; Lei M
Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
[TBL] [Abstract][Full Text] [Related]
43. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
Liu G; Wang W; Wan Y; Ju X; Gu S
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
[TBL] [Abstract][Full Text] [Related]
44. In silico research to assist the investigation of carboxamide derivatives as potent TRPV1 antagonists.
Wang J; Li Y; Yang Y; Du J; Zhang S; Yang L
Mol Biosyst; 2015 Nov; 11(11):2885-99. PubMed ID: 26248221
[TBL] [Abstract][Full Text] [Related]
45. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
Wang Y; Wu M; Ai C; Wang Y
Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
[TBL] [Abstract][Full Text] [Related]
46. 3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors.
Mella-Raipán J; Hernández-Pino S; Morales-Verdejo C; Pessoa-Mahana D
Molecules; 2014 Mar; 19(3):2842-61. PubMed ID: 24603555
[TBL] [Abstract][Full Text] [Related]
47. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
De Freitas GB; da Silva LL; Romeiro NC; Fraga CA
Eur J Med Chem; 2009 Jun; 44(6):2482-96. PubMed ID: 19249138
[TBL] [Abstract][Full Text] [Related]
48. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
49. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Balupuri A; Balasubramanian PK; Cho SJ
Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
[TBL] [Abstract][Full Text] [Related]
50. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
51. Insights into ET(A) subtype selectivity of benzodiazepine endothelin receptor antagonists by 3D-QSAR approaches.
Xia J; Li J; Sun H
J Mol Model; 2012 Apr; 18(4):1299-311. PubMed ID: 21748330
[TBL] [Abstract][Full Text] [Related]
52. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
53. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
54. Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles.
Lorca M; Morales-Verdejo C; Vásquez-Velásquez D; Andrades-Lagos J; Campanini-Salinas J; Soto-Delgado J; Recabarren-Gajardo G; Mella J
Molecules; 2018 May; 23(5):. PubMed ID: 29772697
[TBL] [Abstract][Full Text] [Related]
55. Binding site analysis of CCR2 through in silico methodologies: docking, CoMFA, and CoMSIA.
Kothandan G; Gadhe CG; Madhavan T; Cho SJ
Chem Biol Drug Des; 2011 Jul; 78(1):161-74. PubMed ID: 21294847
[TBL] [Abstract][Full Text] [Related]
56. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA.
Pirhadi S; Ghasemi JB
Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
58. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
[TBL] [Abstract][Full Text] [Related]
59. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
60. 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
Chaube U; Chhatbar D; Bhatt H
Bioorg Med Chem Lett; 2016 Feb; 26(3):864-874. PubMed ID: 26764189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
